Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy

Details for Australian Patent Application No. 2002307793 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/330,118 19.10.01 US

3 July 2003 Application Open to Public Inspection

Published as AU-B-2002307793

25 January 2007 Application Accepted

Published as AU-B-2002307793

31 May 2007 Standard Patent Sealed

7 January 2010 Application for Amendment

The nature of the amendment is: Amend the name of the inventor to add co-inventor Breitbart, Eyal . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 26 239 George Street Brisbane QLD 4000 2003

29 April 2010 Amendment Made

The nature of the amendment is: Add the co-inventor Breitbart, Eyal

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.